
Aescuvest is a Frankfurt-based, pan-European deal-by-deal healthtech venture capital boutique that sources, structures, and co-invests in healthtech rounds alongside business angels, family offices, and corporate partners using a dedicated SPV model. The firm focuses on medical breakthrough innovations including digital drugs, digital devices, and digital detection and diagnosis.
80% of their portfolio is in Healthcare. Their most common stage is series-b (40% of deals). Average disclosed round size is $86.7M (across 3 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Dr. Patrick Pfeffer
Founder and Managing Partner
Sebastian Gührs
Partner
Christoph Bartoschek
Investment Manager
Joerg Diehl
Co-founder
Portfolio Breakdown
Stage Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Unknown | — | Aug 2024 | |
| Series C | $180M | Aug 2024 | |
| Series B | $67M | Oct 2023 | |
| Ppiur imaging | Series A | — | Jul 2023 |
| Series B | $13M | Apr 2023 |
Top Co-Investors
Last updated: 27 September 2026